A Director at Steris is Exercising Options

By Carrie Williams

Yesterday it was reported that a Director at Steris (STEResearch Report), David B. Lewis, exercised options to sell 3,133 STE shares at $32.34 a share, for a total transaction value of $522.1K.

This is Lewis’ first transaction since reporting a Sell transaction on HRB back in June 2017 In addition to David B. Lewis, one other STE executive reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

Based on Steris’ latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $774 million and quarterly net profit of $105 million. In comparison, last year the company earned revenue of $696 million and had a net profit of $47.86 million. The company has a one-year high of $168.12 and a one-year low of $118.18. Currently, Steris has an average volume of 607.17K.

The insider sentiment on Steris has been negative according to 98 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

David B. Lewis’ trades have generated a -6.4% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

STERIS Plc (Ireland) engages in the manufacture of medical and surgical equipment. The company was founded on December 22, 2016 and is headquartered in Dublin, Ireland.